Home » Stocks » Natus Medical

Natus Medical Incorporated (NTUS)

Stock Price: $18.19 USD 0.67 (3.82%)
Updated Aug 5, 2020 4:00 PM EDT - Market closed
After-hours: $18.26 +0.07 (0.39%) Aug 5, 4:05 PM

Stock Price Chart

Key Info

Market Cap 614.86M
Revenue (ttm) 449.04M
Net Income (ttm) 10.73M
Shares Out 33.80M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 5, 2020
Last Price $18.19
Previous Close $17.52
Change ($) 0.67
Change (%) 3.82%
Day's Open 17.52
Day's Range 17.52 - 18.39
Day's Volume 428,930
52-Week Range 17.37 - 34.89

More Stats

Market Cap 614.86M
Enterprise Value 624.49M
Earnings Date (est) Oct 21, 2020
Ex-Dividend Date n/a
Shares Outstanding 33.80M
Float 33.26M
EPS (basic) 0.31
EPS (diluted) -0.42
FCF / Share 1.91
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 10.49%
Payout Ratio n/a
Shares Short 995,306
Short Ratio 2.87
Short % of Float 2.91%
Beta 0.88
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 9.53
PS Ratio 1.37
PB Ratio 1.58
Revenue 449.04M
Operating Income 18.72M
Net Income 10.73M
Free Cash Flow 64.49M
Net Cash -9.64M
Net Cash / Share -0.29
Gross Margin 66.50%
Operating Margin 4.17%
Profit Margin 2.20%
FCF Margin 14.36%
ROA 0.74%
ROE -0.32%
ROIC 5.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 0
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Hold

Price Target

$36.00*
Low
36.0
Current: $18.19
High
36.0
Target: 36.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue495531501382376356344292233218
Revenue Growth-6.73%5.97%31.18%1.6%5.63%3.41%17.73%25.5%6.63%-
Gross Profit292304281235228214202163131130
Operating Income-15.67-24.568.7255.2653.4745.8534.665.11-10.3317.93
Net Income-15.67-22.94-20.2942.5937.9232.4823.153.82-11.1811.94
Shares Outstanding33.7033.1132.5632.4632.3531.5029.9929.0328.5728.09
Earnings Per Share-0.47-0.69-0.621.291.141.000.750.13-0.390.41
EPS Growth---13.16%14%33.33%476.92%---
Operating Cash Flow60.0633.0219.7372.6936.8542.1436.8019.3922.7511.46
Capital Expenditures-5.33-7.88-4.07-3.19-4.07-4.24-1.83-2.25-4.18-4.15
Free Cash Flow54.7325.1515.6669.5032.7837.9034.9717.1518.577.30
Cash & Equivalents63.3056.3788.9524882.4766.5656.1123.0632.8229.39
Total Debt72.59104154140--38.0232.860.900.89
Net Cash / Debt-9.29-48.10-65.3310882.4766.5618.09-9.8031.9228.50
Assets623638710649479435429392315331
Liabilities20624028823288.7982.1112112356.5366.98
Book Value416398422417391353308269258264
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Natus Medical Incorporated
Country United States
Employees 1,484
CEO Jonathan A. Kennedy

Stock Information

Ticker Symbol NTUS
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: NTUS

Description

Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders; head-cooling products for the treatment of brain injury in newborns; and incubators to control the newborn's environment. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, and governmental agencies. The company was founded in 1987 and is headquartered in Pleasanton, California.